Sorry, you need to enable JavaScript to visit this website.

Greenstone LLC Introduces Ziprasidone HCL Capsule
Authorized Generic of GEODON®

PEAPACK, N.J., April 2012 — Greenstone LLC, the U.S.-based generic pharmaceutical subsidiary of Pfizer Inc. (NYSE: PFE), is pleased to announce the introduction of Ziprasidone HCl Capsules to its ever-expanding generic pharmaceutical product line. The product is offered in dosage strengths of 20 mg, 40 mg, 60 mg, and 80 mg capsules.

Greenstone's Ziprasidone HCl Capsules product is the authorized generic of, and thereby fully substitutable for, GEODON® (ziprasidone HCl) Capsules. Their new authorized generic complements Greenstone's consistently growing line of products, and is backed by the power and scale of Pfizer's 162- year worldwide reputation for a commitment to integrity, quality, and supply reliability. As a subsidiary of Pfizer, Greenstone operates under the same values and commitment to bring quality authorized generics to customers, payers, and the patients they serve.

See the Full Prescribing Information for Greenstone's Ziprasidone HCl Capsules at http://www.greenstonellc.com/product-list.aspx. For more information about Greenstone LLC and its products, visit http://greenstonellc.com. GEODON® is a registered trademark of Pfizer Inc.